Aaron Wealth Advisors LLC Takes Position in Humana Inc. $HUM

Aaron Wealth Advisors LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,788 shares of the insurance provider’s stock, valued at approximately $725,000.

Other institutional investors have also added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Humana by 16.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider’s stock worth $300,728,000 after purchasing an additional 158,528 shares in the last quarter. Focus Partners Wealth boosted its position in shares of Humana by 104.2% during the first quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock worth $1,701,000 after buying an additional 3,281 shares during the period. Swedbank AB grew its holdings in shares of Humana by 5.3% during the second quarter. Swedbank AB now owns 100,397 shares of the insurance provider’s stock worth $24,545,000 after buying an additional 5,032 shares in the last quarter. Circle Wealth Management LLC bought a new position in shares of Humana during the first quarter worth about $425,000. Finally, Kera Capital Partners Inc. acquired a new stake in Humana in the 2nd quarter valued at approximately $253,000. 92.38% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on HUM shares. Wells Fargo & Company upped their price target on Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Barclays reduced their target price on shares of Humana from $245.00 to $234.00 and set an “equal weight” rating for the company in a report on Tuesday, November 25th. Royal Bank Of Canada lifted their price target on shares of Humana from $283.00 to $322.00 and gave the company an “outperform” rating in a research note on Thursday, August 21st. Guggenheim reissued a “buy” rating on shares of Humana in a research report on Friday, October 3rd. Finally, The Goldman Sachs Group decreased their price objective on Humana from $235.00 to $215.00 and set a “sell” rating for the company in a report on Monday, November 24th. Nine equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Humana currently has a consensus rating of “Hold” and an average price target of $294.32.

Humana Stock Performance

HUM opened at $260.25 on Thursday. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The business has a 50 day moving average of $260.48 and a 200-day moving average of $259.01. The stock has a market cap of $31.30 billion, a price-to-earnings ratio of 24.39, a PEG ratio of 1.51 and a beta of 0.46.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a return on equity of 12.86% and a net margin of 1.02%.The business had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. During the same period in the previous year, the firm earned $4.16 EPS. The firm’s revenue was up 11.1% compared to the same quarter last year. On average, equities research analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. Humana’s dividend payout ratio is presently 33.18%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.